ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Division Spotlight
Radiation Protection & Shielding
The Radiation Protection and Shielding Division is developing and promoting radiation protection and shielding aspects of nuclear science and technology — including interaction of nuclear radiation with materials and biological systems, instruments and techniques for the measurement of nuclear radiation fields, and radiation shield design and evaluation.
Meeting Spotlight
ANS Student Conference 2025
April 3–5, 2025
Albuquerque, NM|The University of New Mexico
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Apr 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
May 2025
Nuclear Technology
April 2025
Fusion Science and Technology
Latest News
First astatine-labeled compound shipped in the U.S.
The Department of Energy’s National Isotope Development Center (NIDC) on March 31 announced the successful long-distance shipment in the United States of a biologically active compound labeled with the medical radioisotope astatine-211 (At-211). Because previous shipments have included only the “bare” isotope, the NIDC has described the development as “unleashing medical innovation.”
J. Hosea, J. H. Adler, P. Alling, C. Ancher, H. Anderson, J.L. Anderson,a) J.W. Anderson, V. Arunasalam, G. Ascione, D. Ashcroft, C.W. Barnes,a) G. Barnes, S. Batha,b) M.G. Bell, R. Bell, M. Bitter, W. Blanchard, N.L. Bretz, C. Brunkhorst, R. Budny, T. Burgess,c) H. Bush,e) C.E. Bush,c) R. Camp, M. Caorlin, H. Carnevale, S. Cauffman, Z. Chang,f) C.Z. Cheng, J. Chrzanowski, J. Collins, G. Coward, M. Cropper, D.S. Darrow, R. Daugert, J. DeLooper, H. Duong,h) L. Dudek, R. Durst,f) P.C. Efthimion, D. Ernst,d) J. Faunce, R. Fisher, R.J. Fonck,f) E, Fredd, E. Fredrickson, N. Fromm, G.Y. Fu, H.P. Furth, V. Garzotto, C. Gentile, G. Gettelfinger, J. Gilbert, J. Gioia, T. Golian, N. Gorelenkov,i) B. Grek, L.R. Grisham, G. Hammett, G.R. Hanson,c) R.J. Hawryluk, W. Heidbrink,j) H.W. Herrmann, K.W. Hill, H. Hsuan, A. Janos, D.L. Jassby, F.C. Jobes, D.W. Johnson, L.C. Johnson, J. Kamperschroer, J. Kesner,d) H. Kugel, S. Kwon,e) G. Labik, N.T. Lam,f) P.H. LaMarche, E. Lawson, B. LeBlanc, M. Leonard, J. Levine, F.M. Levinton,b) D. Loesser, D. Long, M.J. Loughlin,k) J. Machuzak,d) D.K. Mansfield, M. Marchlik,e) E. S. Marmar,d) R. Marsala, A. Martin, G. Martin, V. Mastrocola, E. Mazzucato, R. Majeski, M. Mauel,l) M.P. McCarthy, B. McCormack, D.C. McCune, K.M. McGuire, D.M. Meade, S.S. Medley, D.R. Mikkelsen, S.L. Milora,c) D. Mueller, M. Murakami,c) J.A. Murphy, A. Nagy, G.A. Navratil,l) R. Nazikian, R. Newman, T. Nishitani,m) M. Norris, T. O'Connor, M. Oldaker, J. Ongena,n) M. Osakabe,o) D.K. Owens, H. Park, W. Park, S.F. Paul, Yu.I. Pavlov,p) G. Pearson, F. Perkins, E. Perry, R. Persing, M. Petrov,q) C.K. Phillips, S. Pitcher,r) S. Popovichev,p) R. Pysher, A.L. Qualls,c) S. Raftopoulos, R. Ramakrishnan, A. Ramsey, D.A. Rasmussen,c) M.H. Redi, G. Renda, G. Rewoldt, D. Roberts,f) J. Rogers, R. Rossmassler, A.L. Roquemore, E. Ruchov,j) S.A. Sabbagh,l) M. Sasao,o) G. Schilling, J. Schivell, G.L. Schmidt, R. Scillia, S.D. Scott, T. Senko, R. Sissingh, C. Skinner, J. Snipes,d) P. Snook, J. Stencel, J. Stevens, T. Stevenson, B.C. Stratton, J.D. Strachan, W. Stodiek, E. Synakowski, W. Tang, G. Taylor, J. Terry,d) M.E. Thompson, J.R. Timberlake, H.H. Towner, A. von Halle, C. Vannoy, R. Wester, R. Wieland, J.B. Wilgen,c) M. Williams, J.R. Wilson, J. Winston, K. Wright, D. Wong,r) K.L. Wong, P. Woskov,d) G.A. Wurden,a) M. Yamada, A. Yeun,r) S. Yoshikawa, K.M. Young, M.C. Zarnstorff, S.J. Zweben
Fusion Science and Technology | Volume 26 | Number 3 | November 1994 | Pages 389-398
Magnetic Fusion Experiment | Proceedings of the Eleventh Topical Meeting on the Technology of Fusion Energy New Orleans, Louisiana June 19-23, 1994 | doi.org/10.13182/FST94-A40191
Articles are hosted by Taylor and Francis Online.
The deuterium-tritium (D-T) experimental program on the Tokamak Fusion Test Reactor (TFTR) is underway and routine tritium operations have been established. The technology upgrades made to the TFTR facility have been demonstrated to be sufficient for supporting both operations and maintenance for an extended D-T campaign. To date fusion power has been increased to ∼9 MW and several physics results of importance to the D-T reactor regime have been obtained: electron temperature, ion temperature, and plasma stored energy all increase substantially in the D-T regime relative to the D-D regime at the same neutral beam power and comparable limiter conditioning; possible alpha electron heating is indicated and energy confinement improvement with average ion mass is observed; and alpha particle losses appear to be classical with no evidence of TAE mode activity up to the PFUS ∼ 6 MW level. Instability in the TAE mode frequency range has been observed at PFUS > 7 MW and its effect on performance is under investigation. Preparations are underway to enhance the alpha particle density further by increasing fusion power and by extending the neutral beam pulse length to permit alpha particle effects of relevance to the ITER regime to be more fully explored.
